EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSBSLG00000008788
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSBSLG00000013876
Gene Symbol: LOC114849345
3 Cross references
203 Possible Orthologues:

Protein Kinase C Alpha Type

Ensembl ID : ENSBSLG00000017304
Gene Symbol: LOC114846545
3 Cross references
212 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSBSLG00000005343
Gene Symbol: PRKCB
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSBSLG00000019004
Gene Symbol: LOC114852795
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSBSLG00000005927
Gene Symbol: PRKCD
3 Cross references
206 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSBSLG00000003954
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSBSLG00000026623
Gene Symbol: PRKCE
2 Cross references
250 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSBSLG00000023048
Gene Symbol: PRKCH
3 Cross references
223 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSBSLG00000026515
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSBSLG00000021973
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSBSLG00000009557
Gene Symbol: PRKCZ
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).